Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Triheptanoin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 24Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Dojolvi

    02 3UX007

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : UX007

    Triheptanoin

    arrow
    Health 2.0 Conference
    Not Confirmed

    Brand Name : UX007

    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed

    Ultragenyx Pharm Inc

    Triheptanoin

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2019 Revenue in Millions : 3

    2018 Revenue in Millions : 1

    Growth (%) : 163

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : UX007

    Triheptanoin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : UX007

    U.S.A
    arrow
    IPhEB Russia
    Not Confirmed

    Ultragenyx Pharm Inc

    Triheptanoin

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2020 Revenue in Millions : 13

    2019 Revenue in Millions : 3

    Growth (%) : 295

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : UX007

    Triheptanoin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : UX007

    U.S.A
    arrow
    IPhEB Russia
    Not Confirmed

    Ultragenyx Pharm Inc

    Triheptanoin

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2021 Revenue in Millions : 40

    2020 Revenue in Millions : 13

    Growth (%) : 204

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Dojolvi

    Triheptanoin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : Dojolvi

    U.S.A
    arrow
    IPhEB Russia
    Not Confirmed

    Ultragenyx Pharm Inc

    Triheptanoin

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2022 Revenue in Millions : 56

    2021 Revenue in Millions : 40

    Growth (%) : 41

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Dojolvi

    Triheptanoin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : Dojolvi

    U.S.A
    arrow
    IPhEB Russia
    Not Confirmed

    Ultragenyx Pharm Inc

    Triheptanoin

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2023 Revenue in Millions : 71

    2022 Revenue in Millions : 56

    Growth (%) : 27

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Dojolvi

    Triheptanoin

    arrow
    IPhEB Russia
    Not Confirmed

    Brand Name : Dojolvi

    U.S.A
    arrow
    IPhEB Russia
    Not Confirmed

    Ultragenyx Pharm Inc

    Triheptanoin

    Main Therapeutic Indication : Rare Diseases and Disorders

    Currency : USD

    2024 Revenue in Millions : 88

    2023 Revenue in Millions : 71

    Growth (%) : 25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.